Shares of Pharma Mar (OTCMKTS:PHMMF – Get Free Report) passed below its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $93.44 and traded as low as $77.7412. Pharma Mar shares last traded at $77.7412, with a volume of 100 shares.
Pharma Mar Stock Performance
The stock has a 50 day moving average price of $93.53 and a two-hundred day moving average price of $93.44.
Pharma Mar Company Profile
Pharma Mar, SA is a Spanish biopharmaceutical company focused on discovering, developing and commercializing innovative medicines derived from marine organisms. The company specializes primarily in oncology and maintains a research platform dedicated to identifying novel compounds with potential anticancer activity.
Its principal products include Yondelis (trabectedin), an anticancer treatment used in certain cases of advanced soft-tissue sarcoma and ovarian cancer, and Zepzelca (lurbinectedin), a therapy developed for patients with metastatic small-cell lung cancer whose disease has progressed during or after platinum-based chemotherapy.
Recommended Stories
- Five stocks we like better than Pharma Mar
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
- Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
- Why Tesla’s Upside Is About More Than a SpaceX Merger
Receive News & Ratings for Pharma Mar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Mar and related companies with MarketBeat.com's FREE daily email newsletter.
